PI
BCYC

PEAK6 Investments’s Bicycle Therapeutics BCYC Stock Holding History

PEAK6 Investments’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$181K Buy
+8,000
New +$185K ﹤0.01% 2801
2024
Q1 		– Sell
-6,000
Closed -$108K – 4042
2023
Q4 		$108K Buy
+6,000
New +$99.3K ﹤0.01% 3521

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

PEAK6 Investments's BCYC Position: Q3 2024 in Review

PEAK6 Investments reduced its Bicycle Therapeutics (BCYC) stake by 5.3% in Q3 2024, selling an estimated $27.1K and leaving 20,826 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #2352.

PEAK6 Investments first reported a position in BCYC in Q4 2023 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold BCYC as of Q3 2024.

  • PEAK6 Investments held 20,826 shares of Bicycle Therapeutics worth $471K as of Q3 2024.
  • PEAK6 Investments sold 1,174 Bicycle Therapeutics shares in Q3 2024, an estimated $27.1K.
  • Bicycle Therapeutics made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2352 holding.
  • PEAK6 Investments first reported a position in Bicycle Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 105 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.